Thromboprophylaxis With Fondaparinux of Deep Vein Thrombosis and Pulmonary Embolism in the Acutely-ill Medical Inpatients With Thrombocytopenia

Trial Profile

Thromboprophylaxis With Fondaparinux of Deep Vein Thrombosis and Pulmonary Embolism in the Acutely-ill Medical Inpatients With Thrombocytopenia

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Dec 2016

At a glance

  • Drugs Fondaparinux sodium (Primary)
  • Indications Venous thromboembolism
  • Focus Adverse reactions
  • Acronyms FAITH
  • Most Recent Events

    • 02 Dec 2016 Planned End Date changed from 1 Sep 2016 to 1 Sep 2017.
    • 02 Dec 2016 Planned primary completion date changed from 1 Aug 2016 to 1 Aug 2017.
    • 19 May 2016 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top